Accelerated US approval of a first-in-class bispecific antibody (BsAb) therapy offers a new option for a difficult-to-treat blood cancer.
The US Food and Drug Administration...
Nearly 50% of the children diagnosed with neuroblastoma are considered high-risk, where the tumor has spread, making surgery no longer a viable treatment option....
In a recent review published in Natures Signal Transduction and Targeted Therapy Journal, a group of authors explored current and future strategies in the...
Treatment for: MucositisGalera Receives Complete Response Letter from U.S. FDA for Avasopasem ManganeseMALVERN, Pa., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq:...
TOKYO, Aug 08, 2023 - (JCN Newswire) - Aichi Cancer Center and NEC Corporation's research group with Gifu University, Toyama University and Kitasato University...
In the quest for technological advancements that can revolutionize our world, the scientific community has always been captivated by the elusive phenomenon of superconductivity....
In a recent study published in Scientific Reports, a group of researchers investigated the efficacy of a novel intra-tumoral drug delivery carrier in treating...
A recent study from researchers at the University of Colorado Boulder has found that cancer patients using cannabis edibles experience improvements in pain levels,...
